225 related articles for article (PubMed ID: 16618585)
1. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy.
Al-Qaisieh B; Brearley E; St Clair S; Flynn A
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):304-7. PubMed ID: 16618585
[TBL] [Abstract][Full Text] [Related]
2. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
[TBL] [Abstract][Full Text] [Related]
3. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
4. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
5. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
7. Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.
Maguire PD; Waterman FM; Dicker AP
Tech Urol; 2000 Jun; 6(2):85-8. PubMed ID: 10798805
[TBL] [Abstract][Full Text] [Related]
8. Is an 192Ir permanent seed implant feasible for prostate brachytherapy?
Glasgow GP; Dogan N; Mohideen N
Brachytherapy; 2002; 1(4):195-203. PubMed ID: 15062167
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
10. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
[TBL] [Abstract][Full Text] [Related]
11. AnchorSeed for the reduction of source movement in prostate brachytherapy with the Mick applicator implant technique.
Badwan HO; Shanahan AE; Adams MA; Shanahan TG; Mueller PW; Markwell SJ; Tarter TH
Brachytherapy; 2010; 9(1):23-6. PubMed ID: 19762286
[TBL] [Abstract][Full Text] [Related]
12. Improvements in prostate brachytherapy dosimetry due to seed stranding.
Lin K; Lee SP; Cho JS; Reiter RE; DeMarco JJ; Solberg TD
Brachytherapy; 2007; 6(1):44-8. PubMed ID: 17284385
[TBL] [Abstract][Full Text] [Related]
13. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial.
Kaplan ID; Meskell PM; Lieberfarb M; Saltzman B; Berg S; Holupka EJ
Brachytherapy; 2004; 3(1):7-9. PubMed ID: 15110307
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors.
Steggerda MJ; van der Poel HG; Moonen LM
Radiother Oncol; 2008 Jul; 88(1):108-14. PubMed ID: 18039548
[TBL] [Abstract][Full Text] [Related]
16. Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy.
Aronowitz JN; Michalski JM; Merrick GS; Sylvester JE; Crook JM; Butler WM; Mawson C; Pratt D; Naidoo D; Karolczuk K
Am J Clin Oncol; 2010 Apr; 33(2):164-7. PubMed ID: 20010076
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
Potters L; Calugaru E; Jassal A; Presser J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
[TBL] [Abstract][Full Text] [Related]
18. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
19. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
[TBL] [Abstract][Full Text] [Related]
20. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
